Lipitor Buyers Ask 3rd Circ. To Keep Pay-For-Delay Fight

By Dan Packel (September 27, 2016, 3:35 PM EDT) -- Attorneys for national pharmacies and wholesale drug distributors told the Third Circuit on Tuesday that their dismissed suit accusing Pfizer and Ranbaxy of a pay-for-delay scheme over the cholesterol drug Lipitor did not belong in the Federal Circuit, in an argument the appeals court confined to the question of jurisdiction....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!